From Silent Epidemic to Measurable Value

Rethinking Alzheimer’s Through a Health Systems Lens 17.11.25

Our latest article reframes Alzheimer’s disease (AD) as a health system risk multiplier, exploring the knock-on effects of the disease and its management on global health systems. Louise Hogg, our Market Access director, explores:

  • Cost structures: elevated healthcare costs related to heightened risks of health issues outside of disease management
  • Diagnostic pathways: inequitable diagnosis, treatment, and support structures
  • Workforce needs: short supply of neurologists and geriatricians in many regions 

Download and read the paper to discover Ipsos’ commentary on the real-world evidence (RWE) and health economics and outcomes research (HEOR) opportunities in the Alzheimer’s disease space.

Related news

  • [Webinar] KEYS: THE MIDDLE CLASS: In Crisis?
    Society Webinar

    [Webinar] KEYS: THE MIDDLE CLASS: In Crisis?

    At our next KEYS webinar, we’ll be sharing on-the-ground perspectives as people give us their in-the-moment takes on how they see their lives - and their status in life - these days. Along the way we’ll hear about freedom (in the US), familismo (in Mexico) and understatedness (in the UK).
  •  [Webinar] KEYS: Global Trends - The Uneasy Decade
    Global Trends Events replay

    [Webinar] KEYS: Global Trends - The Uneasy Decade

    At the next episode of our KEYS webinar, the Ipsos Global Trends team will be launching the findings of our latest report. This 9th edition explores how the trends that will shape the future are evolving, as the uneasy decade continues.
  •  [Webinar] KEYS: Uncharted Territory
    Economy Events replay

    [Webinar] KEYS: Uncharted Territory

    The next episode of our KEYS webinar series is dedicated to what we’ve learned so far during 2025. Are we adapting fast enough? And are there areas where we need to change course?